Details for New Drug Application (NDA): 016765
✉ Email this page to a colleague
NDA 016765 describes FLUOROPLEX, which is a drug marketed by Chartwell Rx and Elorac and is included in two NDAs. Additional details are available on the FLUOROPLEX profile page.
The generic ingredient in FLUOROPLEX is fluorouracil. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
The generic ingredient in FLUOROPLEX is fluorouracil. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 016765
| Tradename: | FLUOROPLEX |
| Applicant: | Elorac |
| Ingredient: | fluorouracil |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016765
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
